Cancer immunotherapy gets assist from micro-scale engineering

Fred Hutch’s Dr. Matthias Stephan adapted a patented strategy to deliver activated immune cells to solid tumors via a nickel-titanium micromesh that improves T-cell delivery and opens up new applications in mouse models.

Read the full article here

Related Articles